中證網(wang)訊（記者(zhe) 宋維東）哈(ha)(ha)(ha)(ha)(ha)藥(yao)股(gu)(gu)份(fen)（600664）12月9日(ri)晚公(gong)告(gao)稱，公(gong)司(si)(si)控(kong)(kong)股(gu)(gu)股(gu)(gu)東哈(ha)(ha)(ha)(ha)(ha)藥(yao)集團當日(ri)完成增(zeng)資(zi)(zi)擴股(gu)(gu)事宜(yi)的(de)外商投資(zi)(zi)企(qi)(qi)業變(bian)更備案工作，增(zeng)資(zi)(zi)擴股(gu)(gu)事宜(yi)的(de)全部(bu)程序已(yi)履(lv)行(xing)完畢。增(zeng)資(zi)(zi)擴股(gu)(gu)事宜(yi)完成后(hou)，哈(ha)(ha)(ha)(ha)(ha)藥(yao)集團由國有控(kong)(kong)股(gu)(gu)企(qi)(qi)業變(bian)為國有參(can)股(gu)(gu)企(qi)(qi)業，哈(ha)(ha)(ha)(ha)(ha)藥(yao)集團的(de)控(kong)(kong)制(zhi)權由哈(ha)(ha)(ha)(ha)(ha)爾濱市國資(zi)(zi)委(wei)(wei)擁有變(bian)更為無實(shi)控(kong)(kong)人(ren)，公(gong)司(si)(si)實(shi)控(kong)(kong)人(ren)也(ye)由哈(ha)(ha)(ha)(ha)(ha)爾濱市國資(zi)(zi)委(wei)(wei)變(bian)更為無實(shi)控(kong)(kong)人(ren)。哈(ha)(ha)(ha)(ha)(ha)藥(yao)股(gu)(gu)份(fen)表示，本次增(zeng)資(zi)(zi)僅(jin)為控(kong)(kong)股(gu)(gu)股(gu)(gu)東層面的(de)股(gu)(gu)權變(bian)動(dong)，對(dui)公(gong)司(si)(si)日(ri)常生(sheng)產經(jing)營沒有直接影(ying)響，公(gong)司(si)(si)日(ri)常生(sheng)產經(jing)營穩定。